Laneige Triple Sunscreen (AMOREPACIFIC)


Welcome to the PulseAid listing for the Laneige Triple Sunscreen drug offered from AMOREPACIFIC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: AMOREPACIFIC
NON-PROPRIETARY NAME: AVOBENZONE, OCTISALATE, HOMOSALATE, and OCTOCRYLENE
SUBSTANCE NAME: AVOBENZONE; OCTISALATE; HOMOSALATE; OCTOCRYLENE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2014-11-20
END MARKETING DATE: 0000-00-00


Laneige Triple Sunscreen HUMAN OTC DRUG Details:

Item DescriptionLaneige Triple Sunscreen from AMOREPACIFIC
LABELER NAME: AMOREPACIFIC
DEA SCHEDULE:
ACTIVE STRENGTH: 1500; 2250; 4500; 4500(mg/50mL; mg/50mL; mg/50mL; mg/50mL)
START MARKETING DATE: 2014-11-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43419-765_cba8b903-850f-4160-a396-67c8cec8bc2d
PRODUCT NDC: 43419-765
APPLICATION NUMBER: part352

Other AVOBENZONE; OCTISALATE; HOMOSALATE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AHAVA Dead Sea Laboratories LtdAHAVA ACTIVE DEADSEA MINERALS
AMOREPACIFICLaneige Triple Sunscreen
Carma Laboratories, Inc.CARMEX strawberry lip balm BROAD SPECTRUM SPF 15 SUNSCREEN